Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-08-19

Clinical Trial Update: Gelatin in ICU and Sepsis [Phase 4]

View source ↗

Summary

Phase 4 trial of gelatin in ICU patients with hypovolemia was terminated; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Gelatin (gelatin)

Snippet

Sponsor: B. Braun Melsungen AG | Conditions: Hypovolemia | Phase 4 | Status: TERMINATED | Results posted: 2025-08-19